A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
Conditions: Healthy; Type 1 Diabetes Mellitus Interventions: Drug: LY3938577; Drug: Placebo; Drug: Insulin Degludec; Drug: Insulin Lispro Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

Effects of Antipsychotics on Brain Insulin Action in Females
Conditions: Insulin Resistance; Menstrual Cycle; Type 2 Diabetes; Antipsychotics Interventions: Drug: Olanzapine 2.5Mg Oral Tablet; Drug: Placebo; Drug: Insulin Lispro 100 UNT/ML; Drug: Saline Sponsors: Centre for Addiction and Mental Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec
Conditions: Diabetes Mellitus, Type 1 Interventions: Drug: HDV-Lispro; Drug: Lispro Sponsors: Diasome Pharmaceuticlas, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials

A Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of THDB0206 Injection in Healthy Chinese Subjects
Conditions: Healthy Interventions: Drug: THDB0206 injection; Drug: Humalog ®; Drug: BC222insulin lispro injection Sponsors: Tonghua Dongbao Pharmaceutical Co.,Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes
Condition:   Type 2 Diabetes Interventions:   Drug: THDB0206 Injection;   Drug: Insulin Lispro Injection Sponsor:   Tonghua Dongbao Pharmaceutical Co.,Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials